Treatment variables associated with outcome in emergency department patients with suspected sepsis. by Sivayoham, N et al.
Sivayoham et al. Ann. Intensive Care          (2020) 10:136  
https://doi.org/10.1186/s13613-020-00747-8
RESEARCH
Treatment variables associated 
with outcome in emergency department 
patients with suspected sepsis
Narani Sivayoham1* , Lesley A. Blake1, Shafi E. Tharimoopantavida1, Saad Chughtai1, Adil N. Hussain1 
and Andrew Rhodes2
Abstract 
Background: Early treatment is advocated in the management of patients with suspected sepsis in the emergency 
department (ED). We sought to understand the association between the ED treatments and outcome in patients 
admitted with suspected sepsis. The treatments studied were: (i) the time to antibiotics, where time zero is the time 
the patient was booked in which is also the triage time; (ii) the volume of intravenous fluid (IVF); (iii) mean arterial 
pressure (MAP) after 2000 ml of IVF and (iv) the final MAP in the ED.
Methods: We performed a retrospective analysis of the ED database of patients aged ≥ 18 year who met two SIRS 
criteria or one red flag sepsis criteria on arrival, received intravenous antibiotics for a suspected infection and admitted 
between 8th February 2016 and 31st August 2017. The primary outcome measure was all-cause in-hospital mortality. 
The four treatments stated above were controlled for severity of illness and subject to multivariate logistic regression 
and Cox proportional-hazard regression to identify independent predictors of mortality.
Results: Of the 2,066 patients studied 272 (13.2%) died in hospital. The median time to antibiotics was 48 (interquartile 
range 30–82) minutes. The time to antibiotics was an independent predictor of mortality only in those who developed 
refractory hypotension (RH); antibiotics administered more than 55 mins after arrival was associated with an odds ratio 
(OR) for mortality of 2.75 [95% confidence interval (CI) 1.22–6.14]. The number-needed-to-treat was 4. IVF > 2000 ml 
(95% CI > 500– > 2100), except in RH, and a MAP ≤ 66 mmHg after 2000 ml of IVF were also independent predictors of 
mortality. The OR for mortality of IVF > 2,000 ml in non-RH was 1.80 (95% CI 1.15–2.82); Number-needed-to-harm was 
14. The OR for morality for a MAP ≤ 66 mmHg after 2000 ml of IVF was 3.42 (95% CI 2.10–5.57). A final MAP < 75 mmHg 
in the ED was associated with, but not an independent predictor of mortality. An initial systolic blood pressure 
of < 100 mmHg has a sensitivity of 63.3% and specificity of 88.4% for the development of RH.
Conclusion: In this study, antibiotics were found to be time-critical in RH. Intravenous fluids > 2000 ml (except in RH) 
and a MAP ≤ 66 mmHg after 2000 ml of IVF were also independent predictors of mortality.
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Background
Early treatment is advocated to reduce mortality in sep-
sis [1–4]. The emergency department (ED) has a critical 
role in the identification and treatment of sepsis as the 
majority of patients in hospital with sepsis are admitted 
as emergencies [5, 6]. It is important to ensure that those 
treatments are delivered in a timely and optimal manner 
to improve outcome whilst minimising harm. Four early 
treatments are advocated in the management of sepsis: 
early antibiotics, intravenous fluids, early diagnosis of 
refractory hypotension (RH) and early commencement of 
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vasopressors for RH to achieve a minimum mean arterial 
pressure (MAP) of 65 mmHg [1, 2].
Antibiotics are crucial to the management of sepsis. 
The relationship between the timing of antibiotic 
delivery and outcome is controversial. Some studies 
support early antibiotics, whereas others have found 
no impact on mortality [7–10]. In some studies where 
a significant proportion of the study population had 
refractory hypotension, early antibiotics were found 
to be associated with a reduction in mortality [7, 8]. 
Attempting to deliver early antibiotics in suspected sepsis 
has led to antibiotics being delivered to patients who do 
not have a final diagnosis of an infection and risks the 
development of antibiotic resistance. We have found that 
approximately 9% of patients receiving early antibiotics in 
the ED did not have a final diagnosis of an infection [11]. 
Whilst this number will never reach zero, it is important 
to minimise the delivery of unnecessary antibiotics. It is 
therefore important to identify the group of patients in 
whom early antibiotics makes a difference to outcome.
Intravenous fluids (IVF) are important to maintain 
circulating volume in sepsis, but the volume of IVF 
is controversial [12] as some argue it may be harmful 
[13]. Trials are underway to determine the optimal fluid 
regime in sepsis [14, 15].
A low MAP after a bolus of intravenous fluids in known 
to be associated with increased mortality. The Sepsis-3 
[16] definition of refractory hypotension (RH) is the 
need for vasopressors to maintain a MAP > 65  mmHg 
after an adequate fluid bolus. When the lactate measured 
after the fluid bolus is over 2 mmol/l, the RH is termed 
septic shock [17]. Shankar-Hari et  al. [17] performed a 
systematic review and meta-analysis of 44 studies with 
varying definitions of shock. The criteria for defining 
refractory hypotension in the definition above was 
set at a MAP of 65  mmHg and agreed to by a panel of 
experts. In adults, the generally accepted volume of fluid 
before determining if a patient has RH is 2000  ml [18], 
representing 30  ml/kg in the average 70  kg adult. As 
the cut-off point for defining RH was specified and not 
derived, we felt the precise cut-off point for prediction of 
mortality should be studied.
We have previously reported that achieving a final 
MAP of 65 mmHg or more before leaving the ED was an 
independent treatment variable associated with survival 
[19] in a group of patients with sepsis and refractory 
hypotension or a lactate of ≥ 4 mmol/l or both.
Study objectives
1. (i) To understand the association between the time to 
antibiotics and in-hospital mortality in the following 
groups of patients:
a. All patients,
b. Those with RH,
c. Those with a REDS score of 5–12, a group 
who have a mortality rate (MR) similar to 
those with RH.
(ii)To determine the critical time interval from 
arrival for the delivery of antibiotics for the 
patient groups in whom the timing of antibiotics 
was associated with mortality.
(iii)To identify patients on arrival in the ED in whom 
the timing of antibiotics is time-critical.
2) To understand the association between the volume of 
IVF administered in the ED and mortality.
3) To determine the MAP after 2000 ml of IVF that is 
associated with mortality.
4) To understand the association between the final 
MAP in the ED and mortality.
Methods
Study design, time period and setting
This is a retrospective study of prospectively collected 
data. In this study, we combined the derivation and 
validation population we used to derive and validate the 
Risk-stratification of ED suspected Sepsis (REDS) score 
[11]. During the study period there was an expectation, 
guided by the Sepsis CQUIN (Commissioning for Quality 
and Innovation) [20] that patients presenting with red 
flag sepsis [3] receive antibiotics within an hour of arrival. 
This expectation has since been revised to the delivery 
of antibiotics within an hour of diagnosis rather than an 
hour from arrival. The ED is also expected to discharge 
or transfer 95% of patients within 4 h of arrival. The 
antibiotics that were delivered were in accordance with 
the local hospital guidelines for empiric antibiotics.
Participant selection and measurements
Adults who received intravenous antibiotics for the treat-
ment of suspected sepsis and were admitted, were stud-
ied. In addition to the previously collected data, the urea, 
creatinine, the volume of fluid (crystalloids or blood) 
commenced (infusions of ≤ 100  ml were not included) 
in the ED and the time of delivery of the antibiotics were 
noted. The time to delivery of antibiotics was calculated 
from the time of registration (this also represents the tri-
age time) in the ED and administration of antibiotics. A 
history of hypertension was also collected. The systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) 
after completing 2000 ml of intravenous fluids and final 
blood pressure (BP) in the ED were noted and the MAP 
was calculated from these readings. The collected data 
were checked by a second researcher for accuracy. The 
REDS score was calculated for each patient [11].
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Exclusions: the following patients were excluded: (i) 
patients who did not have the time of antibiotic admin-
istration documented and (ii) those who did not have a 
blood pressure recorded after the initial blood pressure 
recording.
Outcome measure
The primary end-point was all-cause in-hospital 
mortality.
Data analysis
Univariate analyses were carried out between survivors 
and non-survivors for the following treatment and 
patient variables: the time to antibiotics, the volume of 
intravenous fluid commenced in the ED, the final MAP 
and the REDS score. In those who received a minimum of 
2000 ml of IVF who had a BP recorded after completion 
of the second litre of fluid, the MAP after the second litre 
was also studied.
The following analyses were carried out:
• To determine if a treatment variable was an 
independent predictor of mortality, multivariate 
logistic regression (MVLR) and Cox proportional-
hazard regression (CPHR) were carried out on the 
four treatment variables stated above, urea, creatinine 
and the REDS score. The latter three patient variables 
were used to control for the severity of illness. The 
populations studied were: (a) all patients, (b) those 
with RH, and (c) those who had a BP measured after 
2000 ml of IVF, and (d) those with a REDS score of 
5–12.
• For treatment variables that were found to be inde-
pendent predictors of mortality, a receiver operator 
characteristic (ROC) curve was constructed and the 
cut-off point identified. The optimum cut-off point 
was determined by the statistical software package. 
The OR for mortality was calculated for this cut-off 
point as was the actual risk reduction (ARR) or actual 
risk increase (ARI); the numbers-needed-to-treat 
(NNT) or harm (NNH) were calculated, respectively.
• If patients with RH were found to benefit from 
time-critical administration of antibiotics, then it 
is important to identify them on arrival. RH is not 
diagnosed until a minimum 2000  ml of fluid are 
administered. Therefore, a patient may be identified 
as requiring time-critical antibiotics after the criti-
cal time has elapsed. Initial SBP, DBP, MAP, respira-
tory rate, heart rate and the shock index (HR/SBP) 
were subject to univariate analysis for the develop-
ment of RH. Those variables that were found to be 
significant on univariate analysis for the develop-
ment of RH had ROC curves constructed and cut-
off points identified. Sensitivities and specificities 
for other more practical cut-off points were also 
studied. In order to limit the number of antibiot-
ics delivered to those in whom it does not make a 
difference to outcome, cut-off points with greater 
specificity than sensitivity for mortality, were cho-
sen. In addition, to limit the number of patients 
who are false negative to this initial criterion, we 
speculated on a safety net.
• The final MAP, a treatment end-point, and the 
MAP after 2000  ml of IVF was studied further 
by constructing a ROC curve for mortality and 
identifying the cut-off point. The MR was calculated 
for these two treatment variables, divided in to 
5  mmHg bands. The MR associated with the final 
MAP was also calculated for those with and without 
a history of hypertension.
Statistics
MedCalc Statistical Software version 18.1 (MedCalc Soft-
ware, Ostend, Belgium) was used for statistical analysis. 
Statistical significance was defined as p < 0.05. Univari-
ate analysis was performed using the Mann–Whitney 
test where data were not normally distributed. The Chi-
square test was used to determine the significance of 
differences in mortality between groups. The odds ratio 
(OR) was calculated to determine the scale of the differ-
ence in mortality between two groups. The area under 
the ROC (AUROC) curve was measured and was deemed 
significant if it and the 95% confidence interval (95% 
CI) were > 0.5. MVLR and the Cox proportional hazards 
regression models were constructed using the ‘Enter’ 
method. Variables were entered if p < 0.05 and removed 
if p > 0.1. For the MVLR model treatment variables that 
are known to be significantly associated with outcome 
were included even if the univariate analysis was not sig-
nificant [21, 22]. Discrimination and calibration of the 
MVLR models were assessed by the AUROC curve and 
the Hosmer–Lemeshow test [23], respectively.
Sample size and missing data
Steill et  al. [24] advocate a minimum ten outcomes 
(deaths) per variable. This study had a maximum four 
treatment variables (time to antibiotics, volume of fluid, 
MAP after 2000  ml of fluid and the final MAP) and a 
maximum of three patient variables, namely the REDS 
score, urea and creatinine. The number of variables stud-
ied in any population or sub-group should have a mini-
mum of ten deaths per variable studied. Patients who 
were missing data for the REDS score were not excluded.
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Results
The baseline characteristics of the study population can 
be found in Table 1 with further details in our previous 
publication [11].
Exclusions can be found in Fig. 1. Of the 2,066 patients 
studied, 1800 (87.1%) met the red-flag criteria [3] for 
antibiotics within an hour. Of the 2,066 patients stud-
ied, 1600 (77.4%) arrived by ambulance; 1047 (50.7%) 
arrived by priority ambulance. Of the 272 non-survivors, 
251 (92.2%) arrived by ambulance, 190 (70%) arrived as 
priority ambulance. Seventeen patients received blood; 
9 received one unit and 8 received two units of blood. 
Each unit of blood was estimated to be 250  ml. None 
of the continuous variables in this study were normally 
distributed.
Results as per study objectives:
(1) (i) To understand the association between the time 
to antibiotics and in-hospital mortality:
a. The whole population.
 Table  2 illustrates the median times and 
interquartile ranges for the time to antibiotics. 
Antibiotics were delivered within 60 min in 1328 
(64.3%) patients and within 240 min in 98.1% of 
the study population; 39 received antibiotics after 
240  min from registration, the longest taking 
446 min.
 Non-survivors received their antibiotics 
significantly sooner (median 44  min) than 
survivors (median 49  min, p = 0.011), Table  2. 
Non-survivors also had significantly higher 
REDS scores than survivors; a median 4 in non-
survivors compared to a median of 2 in survivors. 
On MVLR against the REDS score, to control 
for severity of illness, the timing of antibiotics 
was not an independent predictor of mortality, 
p = 0.89. The finding of the MVLR model was 
confirmed by CPHR analysis.
 Of the 1,328 patients who received antibiotics 
within an hour 183 (13.8%) died, compared to 
89 (12.1%) deaths amongst the 738 patients who 
received antibiotics after 60  min from arrival. 
There was no difference in mortality, p = 0.28.
b. Patients with refractory hypotension
 Univariate analysis of the time to antibiotics 
in 117 patients with RH (Table  3) shows no 
difference between survivors and non-survivors. 
But MVLR against the REDS score, to control for 
severity of illness, revealed the time to antibiotics 
to be an independent predictor of mortality 
(p = 0.03) and confirmed by CPHR (p = 0.022).
c. Patients with a REDS score of 5–12
 The MR in those with RH was 37.6% was similar 
to the 34.8% MR in patients with REDS scores 
of 5–12. MVLR analysis of the 328 patients 
with REDS scores of 5–12, found the time to 
antibiotics was not associated with mortality, 
p = 0.93.
 (ii)To determine the critical time to antibiotics
 The time to antibiotics was an independent pre-
dictor of mortality only in patients who were 
found to have RH. A ROC curve was constructed 
for the time to antibiotics, for mortality. The 
AUROC curve was 0.6 (95% CI 0.502–0.69) and 
the cut-off point for association with mortal-
Table 1 Baseline characteristics of study population
Variable Median [interquartile range] 
or number (percentage); total 
2066 patients
Age 71 [54–82] years
Sex (male) 1,035 (50.1%)
Malignancy 413 (20%)
Refractory hypotension 117 (5.7%)
Admission to the intensive care unit 253 (12.2%)
Mortality 272 (13.2%)
Hospital length of stay (days) 6 [3–13] days
Fig. 1 Patient flow diagram
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ity was at > 55  min (95% CI 17–65). Of the 80 
patients who received antibiotics at or within 
55  min from arrival, 24 died (MR 30%) com-
pared to 20 deaths amongst the 37 (MR 54.1%) 
who received antibiotics after 55  min (range 
56–249 mins), p = 0.015. The OR for mortality if 
antibiotics were delivered > 55  min after arrival 
was 2.75 (95% CI 1.22–6.14). The absolute risk 
reduction was 24.1% and the NNT was 4.
 (iii) Identification of patients on arrival, in whom 
antibiotics is time critical
 Initial SBP, DBP, MAP and SI were significantly 
different in those who developed RH compared 
to those who did not develop RH. This was not 
the case for heart rate and respiratory rate. The 
AUROC for the development of RH was highest 
for initial SBP and MAP. Although the AUROC 
for initial SBP and initial MAP were identical we 
chose to study initial SBP further as this would be 
the most familiar at initial assessment. The cut-
off point for the association of initial SBP to RH 
was a SBP ≤ 107  mmHg. As this is not a practi-
cal number, the test characteristics for an initial 
SBP of < 110 mmHg and < 100 mmHg were stud-
ied. The sensitivity and specificity for a cut-off 
point of < 110  mmHg for initial SBP was 75.2% 
Table 2 Univariate and multivariate logistic regression and Cox proportional hazard regression of patient and treatment 
variables for all patients
Hosmer–Lemeshow test for multivariate logistic regression p = 0.28
IVF intravenous fluid, CI confidence interval, MAP mean arterial pressure, REDS score Risk-stratification of Emergency Department suspected Sepsis score, 
IQR interquartile range, OR Odds Ratio, MVLR multivariate logistic regression
a Statistical significance reached
Treatment 
variable
All n = 2066 
median (IQR)
Survivors 
n = 1794 
median (IQR)
Non-survivors 




















48 (30–82) 49 (31–83) 44 (25–77.5) p = 0.011a 1.00 (0.99–1.00) p = 0.89 1.00 (0.99–1.00) p = 0.97








p = 0.1 0.99 (0.99–0.99) p = 0.0001a 0.99 (0.99–0.99) p = 0.0006a
Final MAP 
(mmHg)
83 (74–93) 84 (75–93) 81 (69–91) p < 0.0001 1.01 (0.99–1.02) p = 0.55 1.00 (0.99–1.01) p = 0.62
Urea (mmol/l) 6.7 (4.6–10.8) 6.3 (4.4–9.5) 12.1 (6.9–19.9) p < 0.0001a 1.07 (1.05–1.09) p < 0.0001a 1.03 (1.02–1.04) p < 0.0001a
Creatinine 
(micromol/l)
89 (67–125) 86 (67–117) 117 (76–192) p < 0.0001a 0.99(0.99–1.00) p = 0.06 0.99(0.99–1.00) p = 0.51
REDS score 3 (2–4) 2 (2–3) 4 (3–6) p < 0.0001a 1.67 (1.55–1.80) p < 0.0001a 1.35 (1.27–1.43) p  < 0.0001a
Table 3 Univariate and  multivariate logistic regression and  Cox proportional-hazard regression analyses of  patient 
and treatment variables in patients with refractory hypotension (RH)
Hosmer–Lemeshow test for multivariate logistic regression p = 0.24
IVF  intravenous fluid, CI confidence interval, MAP mean arterial pressure, REDS score Risk-stratification of Emergency Department suspected Sepsis score, 
IQR interquartile range, OR odds ratio, MVLR multivariate logistic regression
a Statistical significance reached
Treatment 
variable
All n = 117 
median (IQR)
Survivors 
























37 (20–62) 33 (19–53) 46 (22.5–78.5) p = 0.08 1.01 (1.001–1.02) p = 0.03a 1.01 (1.001–
1.012)
p  = 0.022a








p  = 0.26 0.99 (0.99–1.00) p  = 0.10 0.99 (0.99–1.00) p  = 0.067
Final MAP 
(mmHg)
61 (56–68) 62 (56–71) 59.5 (55–65) p = 0.12 0.97 (0.93–1.01) p = 0.14 0.99 (0.96–1.02) p = 0.45
REDS score 7 (6–9) 7 (5–8) 8 (7–10.5) p = 0.001 1.53 (1.23–1.92) p = 0.0002a 1.37 (1.17 – 
1.60)
p = 0.0001a
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and 76.7%, respectively. Similarly, a cut-off point 
of < 100  mmHg had a sensitivity and specific-
ity of 63.3% and 88.4%, respectively. If an initial 
SBP < 100 mmHg were to be implemented as the 
new criteria for early antibiotics, only 301 patients 
would be deemed high-risk requiring antibiot-
ics within an hour of arrival compared to 1,800 
patients who met the red-flag criteria [3]. Patients 
who meet red-flag criteria are expected to receive 
antibiotics within an hour of meeting that criteria.
 The speculated safety net for those who are had a 
SBP of 100 mmHg or more on arrival but became 
hypotensive during their ED stay, would be to 
deliver antibiotics within 30mins of a drop in SBP 
to < 100 mmHg.
(2) To understand the association between the volume 
of IVF administered in the ED and mortality
  In the study population as a whole, the volume of 
fluid was not significantly different between sur-
vivors and non-survivors but when controlled 
for severity of illness by the REDS score, it was an 
independent predictor (Table  2) of mortality. The 
AUROC curve was 0.53 (95% CI 0.51–0.55) with a 
cut-off point of > 2000  ml (95% CI > 500– > 2100). 
Of the 219 patients who received > 2000  ml of 
intravenous fluid 52 died (MR 23.7%) compared 
to 220 death amongst the 1,847 patients (MR 
11.9%) who received ≤ 2000  ml of intravenous flu-
ids, p < 0.0001. Amongst the 117 patients with RH, 
the mortality rate in those who received > 2000 ml 
was 32.5% compared to 46.2% in those who 
received ≤ 2000  ml, p = 0.22. MVLR and CPHR of 
the treatment variables showed that the volume 
of IVF was not an independent predictor of mor-
tality in those with RH (Table  3). Similar analysis 
on the 1949 without RH showed that the volume 
of fluid was an independent predictor of mortal-
ity on MVLR (p = 0.004) and CPHR (p = 0.01). 
Of the 1,949 patients without RH there were 26 
deaths amongst the 141 patients (MR 18.4%) 
who received > 2000  ml of fluid compared to 202 
deaths amongst the 1,808 patients (MR 11.2%) who 
received ≤ 2000 ml, p = 0.014. The OR for mortality 
for IVF > 2000 ml in non-RH is 1.80(95% CI 1.15–
2.82). The number needed to harm was 14.
(3) To determine the MAP after 2000 ml of fluid that is 
associated with mortality
  Of the 674 patients who received a minimum 
2000  ml of IVF, a BP after completion of 2000  ml 
was recorded in 503 patients (Table  4). MVLR 
of the MAP after 2000  ml of IVF against the 
REDS score, revealed that the MAP after 2000  ml 
IVF was an independent predictor of mortality, 
p = 0.02 (Table  4). The ROC curve of the MAP 
after 2000  ml of IVF identified a cut-off point 
of ≤ 66  mmHg for association with mortality; the 
MR for a MAP ≤ 66  mmHg was 31.3% and 13.3% 
for a MAP > 66 mmHg. The OR for mortality after 
2,000  ml of IVF for a MAP ≤ 66  mmHg was 3.42 
(95% CI 2.10–5.57). The MRs associated with the 
MAP, divided in to 5 mmHg bands, after 2000 ml of 
fluid are illustrated in Fig. 2.
(4) To determine to the optimal final blood pressure in 
the ED
Univariate analysis of the final MAP for the study 
population as a whole is shown in Table  2. The ROC 
curve of final MAP shows a cut-off point of ≤ 73 (95% 
CI ≤ 69– ≤ 84) mmHg to be associated with mortal-
ity. However, on MVLR and CPHR the final MAP was 
not an independent predictor of mortality when con-
trolled for severity of illness as per the REDS score. The 
REDS score includes initial and refractory hypoten-
sion. Rounding up this cut-off point for the final MAP 
to the nearest 5  mmHg showed the following: a final 
MAP < 75  mmHg was found in 494 patients of whom 
100 died, a MR of 20.2%. Of the 1572 who had a final 
MAP ≥ 75 mmHg 172 died, a MR of 10.9%, p < 0.0001. 
Figure 2 illustrates the crude mortality rates associated 
with the final MAP divided in to bands of 5 mmHg. The 
graph illustrates the whole study population and the 
population divided in to those with and without a his-
tory of hypertension. A final MAP of ≥ 75  mmHg was 
associated with a lower mortality rate irrespective of a 
history of hypertension.
Discussion
In our study we have explored the impact of the ED 
treatment variables on outcome in patients admitted 
with suspected sepsis. We found the time to antibiotics 
to be an independent predictor of mortality in those who 
developed RH and to have a cut-off point at 55 min from 
arrival. The NNT for the delivery of antibiotics within 
55 min of arrival, was 4. Therefore, in cases of refractory 
hypotension, for every four patients, the timely delivery 
of antibiotics saved one life. A volume > 2000  ml of IVF 
was found to be an independent predictor of mortality 
except in those with RH. A MAP ≤ 66  mmHg after 
2000  ml of fluid was also found to be an independent 
predictor of mortality. A final MAP of ≥ 75  mmHg was 
associated with a lower mortality rate compared to a final 
MAP of < 75 mmHg but not an independent predictor of 
mortality.
The median time to antibiotics was 48  min and over 
98% of patients received antibiotics within four hours 
of registering in the ED. The time to antibiotics was 
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identified as critical in RH. The initial vital sign that 
would identify those who are likely to go in to RH was 
an initial SBP of ≤ 107 mmHg. As this was not a rounded 
number an initial SBP < 100  mmHg, was studied. An 
initial SBP < 100  mmHg had a sensitivity of 63.3% and 
a specificity of 88.4% for the identification of RH. The 
use of an initial SBP of < 100  mmHg to deliver antibiot-
ics within an hour may reduce the number of patients 
receiving early and unnecessary antibiotics. However, 
the reduction in sensitivity for RH may be mitigated 
by a safety net to deliver antibiotics within 30  mins of 
reaching a SBP < 100 mmHg, should the SBP drop below 
100 mmHg after arrival in the ED. Furthermore, we did 
not find the time to antibiotics to be time critical in those 
with a REDS score of 5 or more, a group with a mortality 
rate similar to those with RH.
In a multi-centre study, Seymour et al. [8] studied over 
49,000 ED patients who had the sepsis 3  h- treatment 
bundle commenced within six hours of arrival in the 
ED. The population studied were those with severe 
sepsis [25] and septic shock. This latter group is now 
known as refractory hypotension. Seymour et  al. [8] 
Table 4 Univariate and  multivariate logistic regression and  Cox proportional hazard regression analyses 
of  the  treatments and  the  REDS score of  patients who had a  blood pressure measured after  a  minimum 2000  ml 
of intravenous fluids
Hosmer–Lemeshow test for multivariate logistic regression; p = 0.84
CI confidence interval, MAP mean arterial pressure, REDS score Risk-stratification of Emergency Department suspected Sepsis score IQR interquartile range, OR odds 
ratio, MVLR multivariate logistic regression
a Statistical significance reached
Treatment 
variable
All N = 503 
median (IQR)
Survivors 
N = 419 
median (IQR)
Non-survivors 




















39 (24–62) 39 (24–62) 38.5 (22–67.5) p = 0.71 1.00 (0.99–1.01) p = 0.25 1.00 (0.99–1.01) p = 0.28








p = 0.0003a 1.00 (0.99–1.00) p = 0.77 1.00 (0.99–1.00) p = 0.64
MAP mmHg 
post 2 l fluid 
bolus
77 (66–90) 78 (68–90) 69 (60–88) p = 0.0008a 1.03 (1.00–1.05) p = 0.02a 1.03 (1.00–1.05) p = 0.02a
Final MAP 
(mmHg)
79 (69–89) 80 (71–89) 70.5 (60–82.5) p < 0.0001a 0.99 (0.96–1.02) p = 0.5 0.99 (0.97–1.02) p = 0.5
Urea (mmol/l) 7.7(4.8–13.8) 7(4.5–11.7) 15.5(9–26) p < 0.0001a 1.05 (1.03–1.08) p < 0.0001a 1.03 (1.01–1.04) p = 0.003a
REDS score 4 (2–6) 3 (2–5) 6 (5–8) p < 0.0001a 1.63 (1.42–1.87) p < 0.0001a 1.43 (1.29–1.58) p < 0.0001a
Fig. 2 Mortality rates associated with the final mean arterial pressure (MAP) and the MAP after 2000 ml of intravenous fluid in the ED. ED 
emergency department, l litre
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studied only those with organ dysfunction which is a 
sub-group of the ED population with suspected sepsis. 
They found the risk adjusted mortality rate for the time 
to antibiotics increased by an OR 1.04 for each hour 
delay in the administration of antibiotics. But 45% of the 
population studied had septic shock compared to the 
5.7% satisfying the RH criteria in our study population. 
The findings by Seymour et  al. [8] may be explained 
by the heavy weighting towards septic shock patients 
in their study population. The hourly odds ratio for 
mortality in relation to antibiotic delivery is available 
for those on and not on vasopressors (Seymour et  al. 
[8] Supplementary file Figure S3) but not for those with 
and without shock. The study population categorises 
22,336 patients as having septic shock although only 
16,721 received vasopressors. The OR for mortality with 
each hour delay in antibiotic delivery was significant 
only in those receiving vasopressors and not significant 
in the 32,610 patients who did not receive vasopressors. 
Alam et  al. [9] performed a multi-centre, open label, 
randomised controlled trial of prehospital antibiotics 
in sepsis. The median time to antibiotics in the ED was 
70  mins and the median time to delivering antibiotics 
in the pre-hospital setting was 26 mins before arrival in 
the ED; a median 96  min between the two arms of the 
study. This study found that giving antibiotics in the 
prehospital setting did not improve outcome. Only 3.7% 
of this population had septic shock, a population similar 
to ours. These two studies concur with our finding that 
the timing of antibiotic delivery is critical only in those 
with refractory hypotension but not in the general ED 
population suspected of having sepsis.
We did not find the volume of fluid to be an 
independent predictor of mortality in those who 
developed RH. In fact, in this group, those who 
received over 2000  ml of fluid have a lower mortality 
rate, although this did not reach statistical significance. 
A clearer view could be formed when the current 
on-going trials [14, 15] report their findings. However, 
at volumes of > 2000  ml, we found intravenous fluids 
to be an independent predictor of mortality in those 
without RH, with a number-needed to harm of 14. 
This finding has not been reported before and would 
need external validation. Lane et  al. [26] studied the 
association between prehospital of intravenous fluids 
and in-hospital mortality in patients with sepsis. 
They found prehospital fluids were associated with a 
reduction in mortality [OR 0.73 (95% CI 0.56–0.95)] 
in those with hypotension but not in those without 
hypotension. In the latter group, there was a trend 
towards increased mortality with prehospital fluids but 
this did not reach statistical significance [OR 1.41 (95% 
CI 0.81–2.44)]. These findings of pre-hospital fluid 
administration being associated with reduced mortality 
in those with hypotension and a trend towards 
increased mortality in those without hypotension, is 
in keeping with our study findings. As our study is a 
retrospective observational study, it could be argued 
that there may be other confounders that have not 
been studied may have influenced the outcome. We 
have tried to mitigate this by controlling the volume of 
fluid against the other conditions that would demand 
increased fluids such at the renal function and final 
blood pressure. However, we acknowledge that there 
may be other unknown factors that may have influenced 
the result.
Our study identified that a MAP ≤ 66  mmHg after 
2000  ml of IVF was an independent predictor of 
mortality despite regressing it against the REDS score 
which includes RH. This suggests the current definition 
of RH, the need for vasopressors after a fluid bolus to 
maintain a MAP of ≥ 65  mmHg, may not be sufficient. 
In addition, we found a final of MAP of ≥ 75  mmHg 
was associated with a lower mortality rate but it was 
not an independent predictor or mortality. Our finding 
is supported by the findings by Moman et  al. [27] who 
studied patients with and without acute kidney injury 
(AKI) in septic shock. Those without an AKI had a 
significantly higher median post-resuscitation MAP of 
71 mmHg compared to a median MAP of 66 mmHg in 
those with an AKI. Asfar et al. [28] studied a target MAP 
65–70 and 80–85  mmHg in septic shock and found no 
difference in mortality. But the group who should have 
their MAP titrated to 65–70 mmHg were actually treated 
to a higher MAP. These results suggest that a target MAP 
of ≥ 75 mmHg may be better than a MAP of ≥ 65 mmHg. 
However, as the final MAP was not an independent 
predictor of mortality in our retrospective observational 
study, the association with reduced mortality may be 
a result of a variable that we have not studied. The 
question whether a target MAP of ≥ 75 mmHg is better 
than a target MAP of ≥ 65  mmHg could be resolved 
by a randomised controlled trial, thus eliminating any 
unknown confounders.
Our study has several limitations. Firstly, it is a single 
centre study. Secondly, the number of patients with RH 
is small. Thirdly, it is a retrospective observational stud-
ies. Such studies are not ideal for the assessment of the 
impact of treatments as factors that influence the out-
come may not have been studied. Fourthly, the appro-
priateness of antibiotics was not studied but it is intuitive 
that this may have an impact on outcome. Finally, we 
did not study the other treatment such as intubation and 
commencement of vasopressors that may have influ-
enced outcome.
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Conclusion
In this retrospective single centre study, the time to 
antibiotics was critical only in those who subsequently 
developed refractory hypotension; the cut-off point for 
the delivery of antibiotics was 55 min and was associated 
with an NNT of 4. Intravenous fluid volumes > 2000  ml 
(except in refractory hypotension) was an independent 
predictor of mortality with a number-needed-to-harm of 
14. A MAP ≤ 66 mmHg after 2000 ml of intravenous fluid 
was also found to be independent predictors of mortality 
with an OR for mortality of 3.42 (95% CI 2.10–5.57). A 
final MAP of < 75 mmHg in the ED was associated with 
but not an independent predictor of mortality.
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